Recombinant Influenza Vaccine in Adults under 65 Years of Age. Reply
N Engl J Med
.
2024 Mar 21;390(12):1156.
doi: 10.1056/NEJMc2400767.
Authors
Amber Hsiao
1
,
Bruce Fireman
1
,
Nicola P Klein
1
Affiliation
1
Kaiser Permanente Vaccine Study Center, Oakland, CA nicola.klein@kp.org.
PMID:
38507772
DOI:
10.1056/NEJMc2400767
No abstract available
Publication types
Letter
Comment
MeSH terms
Adult
Humans
Influenza Vaccines* / immunology
Influenza, Human* / prevention & control
Vaccines, Synthetic / immunology
Substances
Influenza Vaccines
Vaccines, Synthetic